Perspective Therapeutics, Inc.CATXNYSE
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-76.33M
↓ 228% vs avg
Percentile
P0
Near historical low
Streak
5 yr
Consecutive declineContracting
Average
$-23.24M
Historical baseline
PeriodValueYoY Change
TTM$-76.33M-5.0%
2024$-72.71M-91.4%
2023$-37.98M-204.5%
2022$-12.47M-56.4%
2021$-7.98M-147.9%
2020$-3.22M+17.8%
2019$-3.91M+28.7%
2018$-5.49M+9.2%
2017$-6.05M+3.4%
2016$-6.26M-